Peter Salgo, MD; John L. Fox, MD, MHA; Michael Kolodziej, MD; Ira M. Klein, MD, MBA, FACP; and Bryan Loy, MD, further explore the use of data in oncology and highlight issues that commonly impact payers.
Dr Fox explains that although billions of dollars are being spent on cancer therapy, payers have no way of collecting, aggregating, and interpreting data regarding the way treatments work in a real-world setting. While other stakeholders may not necessarily believe that payers are interested in clinical information, Dr Fox argues that payers are in fact interested, as this information helps ensure that patients receive the right treatments.
Dr Loy comments that although certain data are available, non-standardized coding affects the use of this information. He notes the disconnect between medical claims and pharmacy claims, and also comments that the services or medications for which a payer provides pre-authorization may not always match up with actual claims paid.
Dr Klein adds that regulatory statutes may stand in the way of the sharing of data. Together, the panelists conclude that changes in regulatory statutes and data collection and processing can help payers determine how therapy options work in the real-world setting, and can help clinicians identify the appropriate treatments for patients. Furthermore, data collected during noninterventional studies can be used in addition to claims data and electronic health record data; however, the format for data collection is not standardized, which presents another barrier to data exchange.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More